Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities

Stress Clinical Trial

Official title:

Oxytocin Buffers Cortisol Responses to Stress in Individuals With Impaired Coping Abilities

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01065610
• Other study ID #: Neurolab_RD_001
• Status: Completed
• Phase: N/A
• First received: February 8, 2010
• Last updated: February 8, 2010
• Start date: January 2008
• Est. completion date: October 2008

Study information

• Verified date: January 2010
• Source: University of Osnabrueck
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: October 2008
• Est. primary completion date: October 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• male

Exclusion Criteria:

• psychological disorders

• drug abuse

• cigarette smoking

• coronary diseases

• nervous system diseases

Study Design

N/A

Related Conditions & MeSH terms

• Coping Skills
• Oxytocin
• Stress

Intervention

Drug:
• Oxytocin

• Placebo

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Osnabrueck

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Salivary Cortisol